The UCSF Department of Dermatology, in partnership with the San Francisco Board of Supervisors and the Chinatown Public Health Clinic, will offer free skin cancer screenings in Chinatown to mark National Skin Cancer Awareness Month.

UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.

Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.

Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. 

May 2011